Market Update Graphic
Source: The Market Online
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been up half a percent at 8,030 points in early afternoon trade.

Nine Entertainment (ASX:NEC) has been down around 4.6% after CEO Mike Sneesby resigned. The trouble plagued company’s share price has fallen 57% during Mr. Sneesby’s tenure and his exit ends a difficult few months.

Nine’s FY24 results reveal a 3% decline in revenue and turning the company around will be a key goal of the new CEO.

Nine has been around $1.19 and is also trading ex-dividend today.

Sectors are mostly in the green and IT has surged up around 2%, followed by Energy up around 1.75%, and Real Estate and Utilities – both up around 1%.

Company News

Clarity Pharmaceuticals Ltd (ASX:CU6) has been up around 2.5% after reporting positive results from its theranostic prostate cancer trial – known as SECURE. Data from all 3 patients indicate the drug is safe for use in high doses.  

Clarity Pharmaceuticals has been exchanged at $7.55.

AML3D (ASX:AML) has been up more than 19% on news of a license to expand delivery of 3D printed partsto the US Navy. The agreement will see the company work with key suppliers and teams within the US Navy to print, test and validate a wider range of submarine parts.

The contract is open ended and is seen by the company as a consolidation of its relationship with the US Navy.

ASL3D has been 15.5 cents.

More From The Market Online
Organised crime concept

Panic, paranoia, and gangland politics: HotCopper users react to Dubber’s missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due…
The Market Online Video

ASX Market Update: Bourse nears record approaching week’s end | November 22, 2024

The bourse is near record territory to close out the week on the back of a…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…